In an interview at Fierce Pharma Week, Genentech's chief marketing officer Zoë Lazarre described AI as a kind of protective gear—an "armor, or a digital backpack"—that her teams can carry into their work. The metaphor suggests AI is not a replacement for human judgment but a supporting tool that enables better and quicker decisions, particularly in the fast-moving world of pharmaceutical marketing.
Lazarre emphasized the importance of experimental marketing, where teams test and learn rather than rely on static campaigns. AI fits into this approach by providing insights that would otherwise take longer to surface, helping the company respond to patient needs more nimbly. She also pointed to what she called the "last mile gap"—the distance between having a therapy and ensuring patients actually receive and benefit from it.
Because this is a single-source report, there are no contrasting views to compare. The interview offers a snapshot of how one major biotech executive views AI's role in marketing: not as a cure-all, but as a practical layer of support that can help close the gap between scientific innovation and real-world patient impact.